Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: Carcinoma, Hepatocellular trials
The registry lists 14 Carcinoma, Hepatocellular studies with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor. 9 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 8No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast CancerNot yet recruitingNCT07880106
- TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCCRecruitingNCT07658833
- Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06749678Not applicable
- mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan CriteriaRecruitingNCT06607107Phase 2
- Postoperative Adjuvant Therapy of Donafenib for Hepatocellular CarcinomaRecruitingNCT06581315Not applicable
- FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver TransplantationNot yet recruitingNCT06409637Phase 1/2
- Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT05924997Phase 1/2
- Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver TransplantationRecruitingNCT05475613Phase 2
- mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCCRecruitingNCT05412589Phase 2
- Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft RejectionStatus unknownNCT05913583
- TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver CancerStatus unknownNCT05550025Phase 2
- HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCCStatus unknownNCT05493332Phase 2
- Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After SurgeryCompletedNCT04962958Phase 2
- Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver ResectionStatus unknownNCT02131441Not applicable